Topics:

Big Data Biopharma Forum Slideshow

Tools

Last week, I traveled to San Francisco with my colleagues from Fierce for the J.P. Morgan Healthcare Conference. Like other groups, we hosted our own event, the Big Data Biopharma Forum, enhancing our presence during the industry's unofficial kickoff week of the year. With the hangover from too much hype and buzz around Big Data, we invited biotech and informatics gurus to the stage to cut through the noise and give our audience their insights on how Big Data is improving drug R&D and healthcare.

Here are some views and sound bites from the sold-out event, featuring GlaxoSmithKline ($GSK) Senior Vice President Lon Cardon, Warp Drive Bio CEO Alexis Borisy, AstraZeneca ($AZN) R&D Information Vice President John Reynders and New Enterprise Associates General Partner Dave Mott. -- Ryan McBride (email | Twitter)